advanced plaques. 8 In mouse lesions, CD8 + T cells predominate early immune responses 9 and accumulate with CD4 + T cells in all stages of plaque development. 10 And yet, despite reports of their presence and predominance in human and in early mouse lesions, the definitive role of CD8 + T cells in atherosclerosis and their molecular mechanisms of action remain unresolved.
Previous reports have yielded contradictory reports. Female major histocompatibility complex (MHC) class I-deficient C57BL/6 mice generated by disruption of the β-2 microglobulin (β2m) gene showed increased atherosclerosis by ≈150% in comparison with wild-type C57BL/6 mice after a 15-week high-fat diet (HFD). 11 Because β2m −/− mice decreased CD8 + T cells, 12 the data indirectly suggested that cytotoxic T cells are protective in atherosclerosis. However, the disruption of the β2m gene affects the development of CD8α/α T-cell receptor (TCR)-α/β cells only, whereas the development of CD8α/β TCR-α/β cells mainly depends on Kb and Db proteins and CD8α/α TCR-γ/δ cells develop independently of MHC class I molecules. 13 Indeed, peptide-specific CD8 + CTL clones have been reported in β2m-deficient mice. 14 Also, β2m-deficient mice exhibit iron overload 15 that may aggravate atherosclerosis. 16 In contrast, MHC class I deficiency arising from Tap-1 deficiency does not alter atherosclerosis development in apolipoprotein E-deficient (ApoE −/− ) mice. 17 With the use of the knockout of the CD8 gene in ApoE −/− mice, atherosclerotic lesions remain unchanged between female CD8-competent and -deficient ApoE −/− mice fed a normal chow diet. 18 The study suggested that CD8 + T cells do not have a significant role in atherosclerosis. On the other hand, other reports have provided indirect support for a damaging role of CD8 + T cells in atherosclerosis in that CD8 + T cells are increased in atherosclerotic lesions aggravated by treatment with CD137 agonist, 19 infection with microbes, 20 and PDL1/ L2 deficiency 21 and in a transgenic mouse model of immunemediated arterial inflammation and hypercholesterolemia. 22 Here, we provide compelling direct evidence for an atherogenic role for cytotoxic CD8 + T lymphocytes in atherosclerosis. We show that the depletion of CD8 + T cells using depleting monoclonal antibodies to CD8α or to CD8β in ApoE −/− mice ameliorates atherosclerosis. Conversely, transfer of CD8 + T cells to lymphocyte-deficient mice aggravates atherosclerosis. Transfer studies using CD8 + T cells deficient in perforin (pfp), granzyme B (GZMB), or tumor necrosis factor α (TNFα) suggest that CD8 + T cells promote atherosclerosis by pfp-and GZMB-mediated cytotoxicity and by TNFα-mediated inflammation, as well. Double-immunostaining analysis showed that apoptotic cells in atherosclerotic lesions were identified as macrophages and as endothelial and smooth muscle cells. The data suggest that CD8 + T cells contribute to the development of apoptosis and necrotic cores that are characteristic features of vulnerable atherosclerotic plaques.
Methods

Animals
Wild-type and ApoE −/− mice were from the Precinct Animal Centre, the Alfred Medical Research and Education Precinct. Pfp-, GZMBand interferon γ (IFNγ)-deficient mice were obtained from Mark Smyth, Peter McCallum Cancer Institute, Melbourne. Lymphocytedeficient atherosclerosis-prone mice (ApoE −/− , Rag-2 −/− , common cytokine receptor γ-chain −/− ) and TNFα-deficient mice were maintained at the Animal Facilities, Monash Medical Centre. All mice are on a C57BL/6 background. Animal experiments approved by the Animal Ethics Committee of Alfred Medical Research and Education Precinct were conducted at the Precinct Animal Centre.
CD8-Depleting Antibodies
CD8-depleting antibodies, TIB-210 (rat anti-mouse CD8α-IgG2b) and YTS-156.7 (rat anti-mouse CD8β-IgG2b) were used to deplete CD8 + T cells in the study. The TIB-210-depleting antibody (ATCC) was purified from hybridoma supernatant by using Protein G Sepharose (Amersham Biosciences) according to the manufacturer's instruction, dialyzed against 1×phosphate-buffered saline, and determined the antibody concentration. The YTS-156.7-depleting antibody was a gift from Steve Cobbold, Oxford University, United Kingdom. Rat IgG (Sigma) was used as control for the depletion studies.
CD8 + T-Cell Isolation
CD8 T-cell isolation kit (Miltenyi Biotec) was used to isolate CD8 + T cells from splenocytes. Detailed procedure is described in the onlineonly Data Supplement Methods. Its purity (>90% by fluorescenceactivated cell sorting) and viability (>95% by Trypan-Blue exclusion method) were checked before adoptively transferred (online-only Data Supplement Figure I , online-only Data Supplement Table I ).
Fluorescence-Activated Cell Sorting-Assisted Immune Cell Analysis
All antibodies used for flow cytometry except anti-foxp3 antibody (eBioscience) were from BD Pharmingen. CD4 + and CD8 + T cells were determined by Pacific Blue anti-CD4 and peridinin chlorophyll protein anti-CD8α antibodies, respectively. In some experiments, fluorescein isothiocyanate anti-CD8β antibody was used. B cells were determined by phycoerythrin anti-CD22 antibody. Regulatory T cells were determined by Pacific Blue anti-CD4, allophycocyanin-Cy7 anti-CD25, and phycoerythrin anti-foxp3 antibodies. Natural killer and natural killer T cells were determined by phycoerythrin-Cy7 anti-NK1.1 and fluorescein isothiocyanate anti-TCR-β antibodies. Fluorescencelabeled cells were analyzed by using FACSCanto II flow cytometry system (BD Bioscience) and FACSDiva software (BD Bioscience).
Results
CD8α-and CD8β-depleting Antibodies Deplete CD8+ T Cells
CD8 + T cells express a dimeric CD8 coreceptor consisting of α/α or α/β chains with the vast majority expressing α/β heterodimers. In this study, we used 2 different CD8-depleting antibodies, TIB-210 and YTS-156.7 targeting CD8α and D8β isoforms, respectively, to deplete CD8 + T cells. To test the efficiency of CD8α-depleting antibody, we injected male 6-to 8-week-old ApoE −/− mice (n=3) with 0.3 mg of anti-CD8α antibody twice a week intraperitoneally and assessed the degree of CD8 + T-cell depletion in the peripheral blood at days 3 and 7 after injection. We found that test mice showed CD8 + T-cell depletion of ≈97% in comparison with control mice (onlineonly Data Supplement Figure IIA ). CD8β-depleting antibody showed similar (≈99%) depletion until day 7 after a single dose of 0.5 mg of anti-CD8β antibody given intraperitoneally to male 6-to 8-week-old ApoE −/− mice (n=3) (online-only Data Supplement Figure IIB) . Based on pilot studies, CD8αdepleting antibody was given twice a week to deplete CD8 T cells, whereas CD8β-depleting antibody was injected once a week (online-only Data Supplement Figure IIC and IID).
To examine the role of CD8 T cells in atherosclerosis, we fed 6-to 8-week-old male ApoE −/− mice (n=8) a HFD for 8 weeks while depleting CD8 + T cells with CD8α antibody as described earlier. At the end of the experiment, we found that CD8 + T cells were depleted by ≈86% in the spleen ( Figure 1A ), ≈86% in peripheral blood, and ≈88% in peripheral lymph nodes (online-only Data Supplement Figure IIIA) . In another depletion study, we used anti-CD8β antibody to deplete CD8 + T cells in male 6-to 8-week-old ApoE −/− mice (n=8) while feeding a HFD for 8 weeks. CD8β-depleting antibody also depleted CD8 + T cells by ≈89%, 72%, and 58% and in spleen ( Figure  1B) , peripheral blood, and lymph nodes, respectively (onlineonly Data Supplement Figure IIIB ). However, both CD8α-and CD8β-depleting antibodies did not affect other lymphocytes in spleen ( Figure 1A and 1B), peripheral blood, and lymph nodes (data not shown). Dendritic cell expressing CD11c and CD8α were 80% depleted in lymph nodes and spleen by CD8α-, but not by CD8β-depleting antibody ( Figure 1C ).
CD8 + T-Cell Depletion Ameliorates Atherosclerosis
Next, we examined whether CD8 + T-cell depletion affects atherosclerosis in ApoE −/− mice. CD8α antibody-treated ApoE −/− mice showed a 34% reduction in total lesion area, a 30% reduction in lipid accumulation as assessed by Oil Red O, and a 33% reduction in CD68 + macrophage accumulation at aortic root atherosclerotic lesions (Figure 2A and 2B ). An atherogenic role conferred by CD8 + T cells was confirmed by CD8β-depleting antibody which showed that CD8 + T-cell depletion reduced atherosclerotic total lesion area by 44%, Oil Red O by 52%, and CD68 macrophage accumulation by 47% ( Figure 2C and 2D). These findings were further substantiated by 72% reduction in lipid accumulation assessed by en face Oil Red O staining of the entire aorta ( Figure 2E ).
CD8α-and CD8β-depleting antibodies did not alter the hyperlipidemia and body weight in mice fed a HFD for 8 weeks ( Figure 2F 
Reduced Atherosclerosis Is Associated With Reduced CD8 + T Cells, Apoptosis, and Necrotic Cores in Lesions
Next, we investigated whether global depletion of CD8 + T cells in hyperlipidemic ApoE −/− mice affects their accumulation in atherosclerotic lesions. We found that the lesion CD8 + T cells were decreased by 84% in ApoE −/− mice treated with CD8αdedpleting antibody ( Figure 3A ). In contrast, CD4 + T cells in atherosclerotic lesions were unaffected ( Figure 3A ). Mature dendritic cells are essential for dendritic cell-mediated T-cell activation and expansion via interaction with CD83L present on T cells. CD83 immunoperoxidase staining revealed that CD83 + mature dendritic cells were unaffected by the CD8αdepleting antibody ( Figure 3A ).
After establishing that global and local CD8 + T-cell depletion reduced atherosclerosis in hyperlipidemic ApoE −/− mice, we set out to investigate the mechanism by which CD8 + T cells promote atherosclerosis. CD8 + T cells, on activation, become cytotoxic T cells and cause target cell lysis via secreting pfp and GZMB, 25 resulting in the promotion of apoptosis-induced inflammation and necrosis. Apoptotic cells as assessed by TUNEL assay and necrotic core area as assessed by hematoxylin and eosin stain were decreased by 64% and 49% ( Figure 3C and 3D), respectively, in ApoE −/− mice treated with CD8α-depleting antibody. Our finding that CD8 + T cells are responsible for apoptosis-induced necrosis is in accordance with literature and provides a mechanism by which CD8 + T cells promote atherosclerosis. We examined if smooth muscle and collagen contents, which are important in plaque stability, are also affected by CD8 + T-cell depletion. Contents of smooth muscle assessed by α-SMactin antibody and collagens assessed by picrosirius red ( Figure 3E and 3F) showed no difference in ApoE −/− mice treated with CD8α-depleting antibody. These results indicated that CD8 + T cells do not play a role in plaque stability in ApoE −/− mice fed a HFD for 8 weeks.
Adoptively Transferred CD8 + T Cells Repopulated Systemically and Locally in Atherosclerotic Lesions
In addition to pfp and GZMB, cytotoxic CD8 + T cells also produce cytokines, and CD8 + T cell-produced TNFα and IFNγ are important in modulation of inflammation. 26 To determine whether CD8 + T cells promote atherosclerosis via pfp and GZMB and to investigate the roles of CD8 + T cell-produced TNFα and IFNγ in atherosclerosis, a total of 6×10 6 CD8 + T cells from different donors were adoptively transferred into lymphocyte-deficient ApoE −/− mice (onlineonly Data Supplement Figure IIE) . At the end of an 8-week HFD, CD8 + T cells had repopulated in the spleen of recipient mice at ≈14% to 25% of that population in ApoE −/− mice ( Figure 4A ) and were also identified in atherosclerotic lesions ( Figure 4B ).
CD8 T Cells Deficient in pfp, GZMB, or TNFα Fail to Increase Atherosclerotic Lesions After Their Transfer Into Lymphocyte-Deficient ApoE −/− Mice
There were no differences in body weight and plasma lipids in all recipient mice transferred with CD8 + T cells in comparison with transfer of saline buffer (data not shown). Atherosclerotic lesion assessment at the end of an 8-week HFD showed that CD8 + T cells deficient in pfp, GZMB, or TNFα did not augment atherosclerosis development in compared with saline buffer group despite their systemic and local presence in atherosclerotic lesions after successful reconstitution. Only wild-type and IFNγ-deficient CD8 + T cells increased total lesion area by 120% and 169%, Oil Red O-stained lipid accumulation by 173% and 146%, and CD68 + macrophage accumulation by 195% and 155%, respectively, in comparison with the saline transfer group ( Figure 4C and 4D). These findings were substantiated by augmented en face Oil Red O lipid staining of the entire aorta by 33% ( Figure 4E ).
Apoptosis and Necrotic Core Are Directly Related to pfp and GZMB-Competent CD8 + T Cells
Cytolytic CD8 + T cells mediate cytotoxic activities via secreted pfp and GZMB. Apoptotic cell analysis by TUNEL assay provided compelling evidence of pfp-and GZMB-mediated apoptosis. TUNEL + cells from both pfp-and GZMB-deficient CD8 + T-cell transfer groups did not differ from those from the saline transfer group. Pfp-and GZMB-competent wildtype and IFNγ-and TNFα-deficient CD8 + T cells showed increased TUNEL + cells at 15%, 10%, and 13%, respectively, in comparison with saline transfer group at 1% ( Figure 5A ). Next, we examined necrotic core areas following adoptive transfer of CD8 + T cells to lymphocyte-deficient mice. In comparison with the saline transfer group, we found that transfer of wild-type or IFNγ-deficient CD8 + T cells into lymphocyte-deficient ApoE −/− , respectively, increased necrotic core areas by 286% and 335%. In contrast, although transfer of pfp-and GZMB-deficient CD8 + T cells failed to increase necrotic areas to the same extent as those of wild-type CD8 + T-cell transfer, their necrotic core areas were still increased by 151% and 171% in comparison with the saline buffer group. TNFα-deficient CD8 + T cells also showed an increase in necrotic core area by 294% in comparison with the saline transfer group ( Figure 5B) . These results suggest that formation of necrotic cores is not only apoptosis induced, but also inflammation mediated.
TUNEL + Cells Colocalize With Macrophages and Endothelial and Smooth Muscle Cells in Atherosclerotic Lesions
We next investigated the cellular targets of CD8 + T cell-mediated apoptosis in atherosclerotic lesions by colocalization of TUNEL + cells with immunologic markers of macrophages, smooth muscle cells and endothelial cells. In the depletion experiment, atherosclerotic lesions that developed in the control antibody-treated group showed colocalization of TUNEL + cells with markers of macrophages and endothelial and smooth muscle cells by double-immunofluorescence staining ( Figure 6A through 6C) . In the adoptive transfer study using immunoenzymatic colocalization, we also found that these same 3 cell types colocalized with TUNEL + cells in atherosclerotic lesions that developed following the transfer of wildtype CD8 + cells into lymphocyte-deficient mice ( Figure 6D ). Together, these findings provide an evidence for macrophages and endothelial and smooth muscle cells as cellular targets of CD8 + T cell-mediated apoptosis in atherosclerotic lesions. Identification of apoptotic endothelial cells and apoptotic smooth muscle cells, as well, in the atherosclerotic cap support a role for CD8 + T cells in the development of vulnerable, rupture-prone atherosclerotic plaques.
Inflammatory Responses Mediated by CD8+ T Cells in Atherosclerotic Lesions
Immunohistochemical and real-time analyses in CD8 + T celldepleted aortic arches showed reduced monocyte chemoattractant protein 1 (MCP-1) (CCR2) and vascular cell adhesion molecule 1 ( Figure 7A through 7C ), suggesting that CD8 + T-cell depletion reduced monocyte/macrophage accumulation by reducing the expression of the monocyte-recruiting chemokine MCP-1 and the adhesion molecule vascular cell adhesion molecule 1. Real-time analysis of proinflammatory cytokines in CD8 + T cell-depleted aortic arches showed reduced IFNγ and interleukin 1β (IL1β) ( Figure 7C) indicating an overall reduced local inflammatory milieu within atherosclerotic lesions. However we did not find any significant changes in TNFα expression in the CD8 + T cell-depleted mice ( Figure 7C ). We found a similar pattern of increased IFNγ and IL1β proinflammatory cytokine expression with the transfer of wild-type CD8 + T cells in comparison with pfp-, GZMB-or TNFα-deficient CD8 + T cells into lymphocyte-deficient ApoE −/− mice ( Figure 8A through 8E). TNFα expression was unaffected, however. The findings suggest that, although TNFα produced by CD8 + T cells has a role in their proinflammatory response, TNFα may also be produced by other inflammatory cells at the local inflammatory site of atherosclerotic lesions; these cells likely include macrophages because they are known to produce TNFα.
Discussion
Here, we investigated the atherogenic role of CD8 + T lymphocytes in the immunopathogenesis of atherosclerosis and their molecular mechanisms of action. Selective CD8 T-cell depletion in the peripheral blood and lymphoid tissues with the use of 2 monoclonal antibodies, ie, CD8α-and CD8β-depleting antibodies, significantly reduced CD8 + T cells within aortic atherosclerotic lesions and reduced atherosclerosis development in hypercholesterolemic ApoE −/− mice. Although CD8α antibody also depleted dendritic cells, this is unlikely to have influenced the outcome given that CD8β antibody that spares dendritic cells also reduced atherosclerosis to the same extent. These results suggest that CD8 + T cells promote atherosclerosis by their infiltration into atherosclerotic lesions. Our identification of ≈160 cells/mm 2 of CD8 + T cells in atherosclerotic lesions ( Figure 3A ) is comparable to a density of 80 to 100 cells/mm 2 reported in human AHA type 5 and 6 atherosclerotic lesions, as defined by a fibrous cap and necrotic core. 8 Our findings of ameliorated atherosclerosis accompanying CD8 + T-cell depletion by CD8 + T-cell-depleting monoclonal antibodies stand in contrast with previous gene knockout studies of CD8 + T cells. These studies showed no change in atherosclerotic lesions using genetic knockouts of the CD8 gene 18 and of the Tap1 gene that resulted in MHC class 1and CD8 T-cell deficiency, 17 These genetic knockout studies are difficult to evaluate because the genetic deletion of single immune factors may produce compensatory effects throughout the immune system. Because CD4 + T cells promote atherosclerosis development, thymic selection and expansion of developing CD4 + T cells in CD8 or MHC class I knockout mice may have compensated for the atheroprotective effects of CD8 + T-cell deficiency. 27 This suggestion is supported by the increase in CD4 + T cells in the Tap1-deficient mice. 17 Tap deficiency may be also be further complicated by activation of natural killer and γδT cells as has been reported in humans with Tap deficiency. 28 The present study using the antibody depletion of CD8+ T cells may explain the difference in outcome given that this approach deletes a fully developed and mature CD8 + T-cell population but leaves the other lymphocyte populations unchanged. Immunization with ApoB-100 peptide reduced atherosclerotic lesions by generating cytotoxic CD8 + T cells directed to dendritic cells that resulted in their reduction at immunization sites and in lesions. 29 ApoB-100 peptide immunization also induced CD8 + CD25 + IL10 + T cells, 29 a potent immunosuppressive regulatory T-cell population. 30 The atherogenicity of CD8 + T cells was confirmed by their adoptive transfer into lymphocyte-deficient mice. 23 Despite only partial reconstitution of ≈15% of the CD8 + T-cell population in the spleen, the transferred CD8 + T cells were found in atherosclerotic lesions that accompanied the augmented atherosclerosis.
The amelioration of atherosclerosis with depleted CD8 + T cells is accompanied by reduced apoptotic cells and necrotic cores in lesions. Conversely, transfer of CD8 + T cells to lymphocyte-deficient mice increased apoptotic cells and necrotic cores. Because necrotic cores likely represent secondary necrosis arising from inefficient clearance of apoptotic cells, 4 the findings suggest that cytotoxic CD8 + T cells contribute to the genesis of apoptotic cells and necrotic cores in atherosclerotic lesions. Our findings are in accord with reports that CD8 + T-cell infiltrates are directly correlated with TUNEL + apoptotic events in human colorectal cancers 31 and that CD8 + T cells are responsible for the apoptosis-induced necrosis in human chronic inflammatory diseases. 32 Transfer of pfp-or GZMB-deficient CD8 + T cells into lymphocyte-deficient ApoE −/− mice partially reconstituted CD8 + T cells in lymphoid compartments and were found in aortic lesions to a level similar to those found with transfer of wild-type CD8 + T cells. However, in striking contrast to the augmented atherosclerosis seen with the transfer of wildtype CD8 + T cells, the transferred pfp-or GZMB-deficient CD8 + T cells failed to augment atherosclerosis and increase by guest on April 13, 2017 http://circ.ahajournals.org/ Downloaded from apoptotic cells or necrotic cores. These data indicate that pfp and GZMB secretion by CD8 T cells is a major mechanism of action by which cytotoxic T cells mediate apoptosis followed by secondary necrosis leading to necrotic core formation in atherosclerotic lesions. The data are consistent with the release of cytotoxic granules containing pfp and GZMB by activated cytotoxic CD8 + T cells to lyse target cells presenting antigenic peptides in the context of MHC class I molecules to the CD8 T-cell receptor. 25 Pfp is the first and limiting step in immune-mediated cytolysis by cytotoxic CD8 + T cells and its absence renders CD8 + T cells unable to exert their cytotoxic effector function. 25 Colocalization studies with TUNEL + apoptotic cells identified macrophages as TUNEL + apoptotic cells in atherosclerotic lesions. The findings are consistent with the report that impaired clearance of apoptotic macrophages is a characteristic feature of atherosclerotic lesions and that this leads to secondary necrosis, a key element in the genesis of necrotic cores in atherosclerotic lesions. 33 Monocyte-derived macrophages appear early in the intimal layer and are the most abundant inflammatory cell type in atherosclerotic lesions. Our colocalization studies with TUNEL + cells suggest that macrophages are target cells for pfp-and GZMB-mediated cytolysis by CD8 + T cells in atherosclerosis. Our previous observation that MHC class I molecules are dramatically upregulated on macrophages within atherosclerotic lesions, as shown by double immunostaining of aortic root sections with MHC class I and macrophage markers 34 is also consistent with this suggestion. Our colocalization studies also identified TUNEL + apoptotic endothelial cells and smooth muscle cells including those in the fibrous cap. CD8 + T lymphocytes are cytolytic to human endothelial cells 5 and smooth muscle cells in injured arteries 6 and also cytotoxic to these cells in vivo. 35 In programmed cell death-1-deficient Ldlr −/− mice, increased CD8 + T cells in the lesions were also associated with more apoptotic cells comprising both smooth muscle cells and nonsmooth muscle. 35 Because oxidized low-density lipoprotein (oxLDL) is taken up by scavenger receptors on macrophages and endothelial and smooth muscle cells, 36 these cells may use MHC class I molecules to present oxLDL-derived peptides to CD8 + T cells. The suggestion is supported by reports that human T lymphocytes are activated by oxLDL 37 and oxLDL induces human cytotoxic T lymphocytes in vitro. 38 Thus, oxLDL is a likely antigen driving the human cytotoxic T-lymphocyte response. Identification of TUNEL + apoptotic cells in macrophages and endothelial and smooth muscle cells suggests that cytolysis of these cells may contribute to the development of ruptureprone atherosclerotic lesions.
In comparison with the transfer of wild-type CD8 T cells into lymphocyte-deficient mice, atherosclerotic lesions assessed by lipid stain and macrophage accumulation were reduced with the transfer of CD8 T cells deficient in TNFα but not in IFNγ. The data suggest that TNFα, not IFNγ, secreted by CD8 T cells contributes to the inflammatory responses in atherosclerosis. This suggestion is supported by the observation that, in comparison with the transfer of wild-type CD8 + T cells, transfer of TNFα-deficient CD8 + T cells reduced the expression of MCP-1, IFNγ, and IL1β but did not affect the generation of TUNEL + apoptotic cells or necrotic cores in atherosclerotic lesions. Our findings are consistent with the established role of TNFα as a potent proinflammatory cytokine 39 and with the report that it promotes the development of atherosclerosis. 40 Our studies indicate the important role of CD8 + T cell-derived TNFα in atherosclerosis. In comparison with the transfer of phosphate-buffered saline, the transfer of wild-type CD8 + T cells into lymphocyte-deficient mice increased IL1β. The data are consistent with the report that IL1β promotes atherosclerosis development. 41 In comparison with the transfer of wild-type CD8 + T cells, transfer of pfpor GZMB-deficient CD8 + T cells also reduced the expression of the chemokine MCP-1(CCR2) and the inflammatory cytokines IFNγ and IL1β. The data suggest that the reduction of cytotoxic activity itself can lead to reduced inflammatory activity in atherosclerotic lesions. The suggestion is consistent with the ability of dying cells to generate a sterile inflammatory response. 42 Cytotoxic CD8 + T lymphocytes are our major defense against a variety of viral and some bacterial infections. 43 CD8 + T cells are pathogenic in a variety of autoimmune diseases. For instance, adoptive transfer of CD8 + T-cell clones from the SKG mouse model of rheumatoid arthritis to athymic nude mice resulted in bone and cartilage destruction, 44 whereas CD8-deficient mice had a lower incidence of collagen-induced arthritis. 45 Activated CD8 + T cells are directly related to disease activity in patients who have systemic lupus erythematosus. 46 Myelin basic protein-specific CD8 + T cells induce severe central nervous system disease in mice that is similar to multiple sclerosis, 47 and CD8 + T cells destroy insulin-secreting pancreatic islet β-cells leading to diabetes mellitus. 48 An approach to target cytotoxic CD8 + T cells has been investigated in experimental autoimmune diseases. CD8 + T-cell depletion by antibody delayed the onset and decreased or reversed the severity of experimental arthritis. 49 A therapeutic approach targeting insulin-reactive CD8 + T cells prevented spontaneous diabetes mellitus in NOD mice. 50 In summary, we provide direct evidence for an atherogenic role for cytotoxic CD8 + T cells and that these cells promote atherosclerosis by the molecular mechanisms of pfp-and GZMB-dependent cytotoxicity and TNFα-induced inflammatory mechanisms, as well. Our findings suggest that CD8 + T cells promote the development of vulnerable atherosclerotic plaques through the development of apoptosis, necrotic cores, and possible thinning of atherosclerotic caps. Furthermore, our findings provide the first insight into the genesis of apoptotic cells and necrotic cores in these vulnerable atherosclerotic lesions and identify lesion macrophages and endothelial and smooth muscle cells as cellular targets of cytotoxic CD8 + T cells. Our findings are entirely consistent with CD8 + T cells as professional cytotoxic T cells that lyse cells infected with intracellular pathogens such as viruses. Targeting CD8 + T cells together with lipid-lowering agents may have the potential to prevent the development of these vulnerable plaques and reduce cardiovascular risks. 
Sources of Funding
Assessment of atherosclerotic lesion at aortic root
Frozen sections (6μm) were cut from the aortic sinus, defined as the region where the valve or valve cusps first become visible to where the left and right coronary arteries branch off 1 .
Slides comprised of 6 cross-sectional areas at 30mm intervals from an aortic root were stained with Oil Red O and examined using light microscope. Total cross-sectional area of lipid deposition was quantified using image analysis software (Optimas, Australia) and averaged. Slides assigned with identification numbers were assessed by another member of laboratory blinded to sample identification.
Assessment of atherosclerosis in total aorta
Whole aortas from ascending aorta to abdominal aorta were cut opened and periaortic fat and blood clot were removed, following by staining with Oil Red-O. Images under light microscope were captured using FVII Olympus camera and lipid deposition was quantified using image analysis software (Optimas, Australia).
AutoMACS isolation of CD8 + T cells
CD8 T cell isolation kit (Miltenyi Biotec.) containing the biotinylated antibodies cocktail (CD4, CD11b, CD45R, DX5 and Ter119a) was used to negatively isolate CD8 + T cells from splenocytes. Donor spleens were disrupted using frosted ends of glass slides and single suspension was made after lysing red blood cells. After incubation with biotinylated antibody cocktail, anti-biotin magnetic microbeads were added into the cell suspension. Unlabelled CD8 + T cells were negatively sorted using autoMACS separator and its purity (>90% by FACS) and viability (>95% by Trypan-Blue exclusion method) were checked before adoptively transferred into recipient mice.
Immunohistochemical analysis
Rat anti-mouse CD68 (Serotec, Raleigh, NC), rabbit anti-α-actin-smooth muscle (α-SMactin) (Abcam, Cambridge, UK), rat anti-mouse CD4 (BD Pharmingen), rat anti-mouse CD8 (BD Pharmingen), rat anti-mouse CD83 (eBioscience) antibodies were used to detect macrophages, smooth muscle cells, CD4 + T cells, CD8 + T cells and mature dendritic cells in atherosclerotic lesions. Host-matched IgG (rat or rabbit IgG) was used as control in immunohistochemical staining procedure.
Frozen sections of the aortic sinus were fixed in ice-cold acetone for 20 minutes and washed with PBS. Quenching of endogenous peroxidase was performed by incubating the slides in 3% hydrogen peroxide in PBS. Normal horse serum (10% in PBS) was used to block nonspecific binding sites, followed by incubation with primary antibodies prepared in blocking solution. Biotinylated goat anti-rat or anti-rabbit immunoglobulins prepared in blocking solution were used in secondary antibody incubation. VECTORSTAIN elite Avidin-Biotin Complex kit (Vector laboratories) and 3,3'-Diaminobenzidine (DAB) were used to generate brown coloration. After counterstaining with haematoxylin and dehydration, slides were mounted with DEPEX.
Slides assigned with identification numbers were assessed by another member of laboratory blinded to sample identification. Quantification of macrophage and smooth muscle accumulation was assessed by CD68-positive or α-SMactin staining area using Optimas software. Cells stained with CD4, CD8 and CD83 were manually counted under light microscopy and corrected to total lesion areas as quantified by Optima software.
Necrotic core assessment
Atherosclerotic lesions at aortic roots were stained with haematoxylin and eosin (H&E) stains. Necrotic core area was defined as a cellular area that was not stained by H&E 2 .
Atherosclerotic lesion area (total intimal area) and acellular area (H&E negative area in atherosclerotic lesions) were quantified using Optimas software. Necrotic core quantification was done by individual who did not have assessed to identification numbers. Total necrotic core areas were expressed as percentage of total atherosclerotic lesion area. Splenocytes were subjected to magnetic sorting procedures as instructed in CD8 T cell isolation kit (Miltenyi Biotec). Differential analysis of negatively-sorted CD8 cells was performed by flow-cytometry (n=3) 
Apoptotic cells assessment
Figure legends
